Allspring Global Investments
PTGX icon

Allspring Global Investments’s Protagonist Therapeutics PTGX Stock Holding History

Allspring Global Investments’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.01M Sell
24,054
-5,862
-20% -$612K ﹤0.01% 996
2026
Q1 		$3.1M Buy
29,916
+25,931
+651% +$2.3M 0.01% 964
2025
Q4 		$347K Buy
+3,985
New +$326K ﹤0.01% 1476
2025
Q1 		– Sell
-5,975
Closed -$231K – 1802
2024
Q4 		$231K Sell
5,975
-97,867
-94% -$4.27M ﹤0.01% 1647
2024
Q3 		$4.67M Buy
103,842
+103,414
+24,162% +$4.18M 0.01% 962
2024
Q2 		$14.8K Sell
428
-1,542
-78% -$45.2K ﹤0.01% 2164
2024
Q1 		$57K Sell
1,970
-563
-22% -$15.3K ﹤0.01% 1929
2023
Q4 		$58.1K Sell
2,533
-5,973
-70% -$105K ﹤0.01% 1868
2023
Q3 		$142K Sell
8,506
-167,023
-95% -$3.24M ﹤0.01% 1865
2023
Q2 		$4.85M Sell
175,529
-48,135
-22% -$1.2M 0.01% 1011
2023
Q1 		$5.14M Buy
223,664
+217,761
+3,689% +$3.66M 0.01% 985
2022
Q4 		$64.4K Sell
5,903
-5,784
-49% -$48.8K ﹤0.01% 2239
2022
Q3 		$98K Buy
11,687
+1,375
+13% +$13K ﹤0.01% 2093
2022
Q2 		$81K Sell
10,312
-16,994
-62% -$205K ﹤0.01% 2123
2022
Q1 		$646K Buy
27,306
+1,935
+8% +$54.5K ﹤0.01% 2111
2021
Q4 		$867K Buy
+25,371
New +$802K ﹤0.01% 2026

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Farallon Capital Management
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
RTW Investments
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Allspring Global Investments's PTGX Position: Q2 2026 in Review

Allspring Global Investments reduced its Protagonist Therapeutics (PTGX) stake by 20% in Q2 2026, selling an estimated $612K and leaving 24,054 shares worth $3.01M. The position accounts for ﹤0.01% of the portfolio, ranked #996.

Allspring Global Investments first reported a position in PTGX in Q4 2021 and has held it in 16 quarters since. The position peaked at $5.14M in Q1 2023. 343 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

  • Allspring Global Investments held 24,054 shares of Protagonist Therapeutics worth $3.01M as of Q2 2026.
  • Allspring Global Investments sold 5,862 Protagonist Therapeutics shares in Q2 2026, an estimated $612K.
  • Protagonist Therapeutics made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #996 holding.
  • Allspring Global Investments first reported a position in Protagonist Therapeutics in Q4 2021 and has held it in 16 quarters since.
  • Allspring Global Investments's Protagonist Therapeutics position peaked at $5.14M in Q1 2023.
  • 343 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.